Advanced Search
Contact | Corporate | Help

Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy

Sponsors:
  • National Eye Institute (NEI)
  • Genentech
  • Allergan
Phases:
  • Phase III
IndicationsAcronym:
LRTforDME+PRP
  • Proliferative Diabetic Retinopathy
  • Diabetic Macular Edema
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Ranibizumab
  • Drug: Triamcinolone Acetonide
  • Behavioral: Sham injection
Enrollment:
381

Additional information about NCT00445003.


SourceSolution © 2008-2012